REPLIGEN CORP — Director's Dealing 2020

Mar 3, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2020-03-01

Reporting Person: Mhatre Rohin (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-03-01	Stock Option (Right to Buy)	$85.60	A	3452	Acquired	2030-03-01	Common Stock (3452)	Direct

Footnotes

F1: The shares vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date.